leadership
confidence high
sentiment neutral
materiality 0.45
Serina Therapeutics appoints Karen J. Wilson to board; Steven Mintz departs
Serina Therapeutics, Inc.
- Karen J. Wilson appointed effective Jan 14, 2025; over 30 years life sciences finance experience, CPA.
- Wilson will serve as Compensation Committee Chair and on the Audit Committee.
- Steven Mintz departs board; no disagreement; Remy Gross replaces as Audit Committee chair.
- Wilson also serves on boards of Connect Biopharma, Elicio Therapeutics, and LAVA Therapeutics.